Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways

Human Molecular Genetics

Volumn 24, Issue 20, 2015, Pages 5901-5914

  Rickard, Amanda M ^a   Petek, Lisa M ^a   Miller, Daniel G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DOUBLE HOMEOBOX 4; TRANSCRIPTOME; UNCLASSIFIED DRUG; DUX4 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN;

ARTICLE; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA METABOLISM; RNA SPLICING; CELL MOTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE CELL; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL DEATH; CELL MOVEMENT; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; RNA SPLICING;

EID: 84943750850     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv315     Document Type: Article

References (42)

1. Deenen, J.C., Arnts, H., van der Maarel, S.M., Padberg, G.W., Verschuuren, J.J., Bakker, E., Weinreich, S.S., Verbeek, A.L. and van Engelen, B.G. (2014) Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology, 83, 1056-1059.
2. Tawil, R. (2008) Facioscapulohumeral muscular dystrophy. Neurotherapeutics, 5, 601-606.
3. Taylor, D.A., Carroll, J.E., Smith, M.E., Johnson, M.O., Johnston, G.P. and Brooke, M.H. (1982) Facioscapulohumeral dystrophy associated with hearing loss and Coats syndrome. Ann. Neurol., 12, 395-398.
4. Gurwin, E.B., Fitzsimons, R.B., Sehmi, K.S. and Bird, A.C. (1985) Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness. Arch. Ophthalmol., 103, 1695-1700.
5. van Overveld, P.G., Lemmers, R.J., Sandkuijl, L.A., Enthoven, L., Winokur, S.T., Bakels, F., Padberg, G.W., van Ommen, G.J., Frants, R.R. and van der Maarel, S.M. (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet., 35, 315-317.
6. de Greef, J.C., Lemmers, R.J., van Engelen, B.G., Sacconi, S., Venance, S.L., Frants, R.R., Tawil, R. and van der Maarel, S.M. (2009) Common epigenetic changes of D4Z4 in contractiondependent and contraction-independent FSHD. Hum. Mutat., 30, 1449-1459.
7. Zeng, W., de Greef, J.C., Chen, Y.Y., Chien, R., Kong, X., Gregson, H.C.,Winokur, S.T., Pyle, A., Robertson, K.D., Schmiesing, J.A. et al. (2009) Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet., 5, e1000559.
8. Wijmenga, C., Hewitt, J.E., Sandkuijl, L.A., Clark, L.N.,Wright, T.J., Dauwerse, H.G., Gruter, A.M., Hofker, M.H., Moerer, P., Williamson, R. et al. (1992) Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet., 2, 26-30.
9. Lemmers, R.J., Tawil, R., Petek, L.M., Balog, J., Block, G.J., Santen, G.W., Amell, A.M., van der Vliet, P.J., Almomani, R., Straasheijm, K.R. et al. (2012) Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat. Genet., 44, 1370-1374.
10. Gabriels, J., Beckers, M.C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S.M., Padberg, G.W., Frants, R.R., Hewitt, J.E., Collen, D. et al. (1999) Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene, 236, 25-32.
11. Lemmers, R.J., van der Vliet, P.J., Klooster, R., Sacconi, S., Camano, P., Dauwerse, J.G., Snider, L., Straasheijm, K.R., van Ommen, G.J., Padberg, G.W. et al. (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science, 329, 1650-1653.
12. Snider, L., Asawachaicharn, A., Tyler, A.E., Geng, L.N., Petek, L.M., Maves, L., Miller, D.G., Lemmers, R.J., Winokur, S.T., Tawil, R. et al. (2009) RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet., 18, 2414-2430.
13. Geng, L.N., Yao, Z., Snider, L., Fong, A.P., Cech, J.N., Young, J.M., van der Maarel, S.M., Ruzzo, W.L., Gentleman, R.C., Tawil, R. et al. (2012) DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev. Cell, 22, 38-51.
14. Bosnakovski, D., Xu, Z., Gang, E.J., Galindo, C.L., Liu, M., Simsek, T., Garner, H.R., Agha-Mohammadi, S., Tassin, A., Coppee, F. et al. (2008) An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J., 27, 2766-2779.
15. Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C.B., Sauvage, S., Matteotti, C., Arias, C., Corona, E.D., Nunez, N.G., Leo, O. et al. (2007) The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul. Disord., 17, 611-623.
16. Wallace, L.M., Garwick, S.E., Mei, W., Belayew, A., Coppee, F., Ladner, K.J., Guttridge, D., Yang, J. and Harper, S.Q. (2011) DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann. Neurol., 69, 540-552.
17. Dandapat, A., Bosnakovski, D., Hartweck, L.M., Arpke, R.W., Baltgalvis, K.A., Vang, D., Baik, J., Darabi, R., Perlingeiro, R.C., Hamra, F.K. et al. (2014) Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene. Cell Rep., 8, 1484-1496.
18. Snider, L., Geng, L.N., Lemmers, R.J., Kyba, M.,Ware, C.B., Nelson, A.M., Tawil, R., Filippova, G.N., van der Maarel, S.M., Tapscott, S.J. et al. (2010) Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet., 6, e1001181.
19. Block, G.J., Petek, L.M., Narayanan, D., Amell, A.M., Moore, J.M., Rabaia, N.A., Tyler, A., van der Maarel, S.M., Tawil, R., Filippova, G.N. et al. (2012) Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production. PloS one, 7, e35532.
20. Sandri, M., El Meslemani, A.H., Sandri, C., Schjerling, P., Vissing, K., Andersen, J.L., Rossini, K., Carraro, U. and Angelini, C. (2001) Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J. Neuropathol. Exp. Neurol., 60, 302-312.
21. Block, G.J., Narayanan, D., Amell, A.M., Petek, L.M., Davidson, K.C., Bird, T.D., Tawil, R., Moon, R.T. and Miller, D.G. (2013) Wnt/beta-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. Hum. Mol. Genet., 22, 4661-4672.
22. Bruce Paterson, R.S. (1972) Myosin synthesis in cultures of differentiating chicken embryo skeletal muscle. Dev. Biol., 29, 113-138.
23. Jones, T.I., Chen, J.C., Rahimov, F., Homma, S., Arashiro, P., Beermann, M.L., King, O.D., Miller, J.B., Kunkel, L.M., Emerson, C.P. Jr. et al. (2012) Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum. Mol. Genet., 21, 4419-4430.
24. Yao, Z., Snider, L., Balog, J., Lemmers, R.J., Van Der Maarel, S.M., Tawil, R. and Tapscott, S.J. (2014) DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum. Mol. Genet., 23, 5342-5352.
25. Luo, W., Friedman, M.S., Shedden, K., Hankenson, K.D. and Woolf, P.J. (2009) GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics, 10, 161.
26. Feng, Q., Snider, L., Jagannathan, S., Tawil, R., van der Maarel, S.M., Tapscott, S.J. and Bradley, R.K. (2015) A feedback loop between nonsense-mediated decay and the retrogene in facioscapulohumeral muscular dystrophy. eLife, 4, e04996.
27. Philips, A.V., Timchenko, L.T. and Cooper, T.A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-741.
28. Wang, J., Pegoraro, E., Menegazzo, E., Gennarelli, M., Hoop, R.C., Angelini, C. and Hoffman, E.P. (1995) Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet., 4, 599-606.
29. Timchenko, N.A., Iakova, P., Cai, Z.J., Smith, J.R. and Timchenko, L.T. (2001) Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell. Biol., 21, 6927-6938.
30. Puppo, F., Dionnet, E., Gaillard, M.C., Gaildrat, P., Castro, C., Vovan, C., Bertaux, K., Bernard, R., Attarian, S., Goto, K. et al. (2015) Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype. Hum. Mutat., 36, 443-453.
31. Caruso, N., Herberth, B., Bartoli, M., Puppo, F., Dumonceaux, J., Zimmermann, A., Denadai, S., Lebosse, M., Roche, S., Geng, L. et al. (2013) Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet., 9, e1003550.
32. Katz, Y., Wang, E.T., Airoldi, E.M. and Burge, C.B. (2010) Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods, 7, 1009-1015.
33. Krom, Y.D., Thijssen, P.E., Young, J.M., den Hamer, B., Balog, J., Yao, Z., Maves, L., Snider, L., Knopp, P., Zammit, P.S. et al. (2013) Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet., 9, e1003415.
34. Lek, A., Rahimov, F., Jones, P.L. and Kunkel, L.M. (2015) Emerging preclinical animal models for FSHD. Trends Mol. Med., 21, 295-306.
35. Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton, S.D., Coppee, F. and Belayew, A. (2011) The FSHD atrophic myotube phenotype is caused by DUX4 expression. PloS one, 6, e26820.
36. Mariot, V., Roche, S., Hourde, C., Portilho, D., Sacconi, S., Puppo, F., Duguez, S., Rameau, P., Caruso, N., Delezoide, A.L. et al. (2015) Correlation between low FAT1 expression and early affected muscle in FSHD. Ann. Neurol., DOI: 10.1002/ ana.24446.
37. Dull, T., Zufferey, R., Kelly, M., Mandel, R.J., Nguyen, M., Trono, D. and Naldini, L. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol., 72, 8463-8471.
38. Love, M.I., Huber,W. and Anders, S. (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 550.
39. Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H. and Kanehisa, M. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res., 27, 29-34.
40. Langmead, B., Trapnell, C., Pop, M. and Salzberg, S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
41. Zhu, L.J., Gazin, C., Lawson, N.D., Pages, H., Lin, S.M., Lapointe, D.S. and Green, M.R. (2010) ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics, 11, 237.
42. Katz,Y.,Wang, E.T., Silterra, J., Schwartz, S.,Wong,B.,Thorvaldsdottir, H., Robinson, J.T.,Mesirov, J.P., Airoldi, E.M. and Burge, C.B. (2015) Quantitative visualization of alternative exon expression from RNA-seq data. Bioinformatics, 31, 2400-2402.